ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, featuring promising improvements across different healthcare and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, more trusted alternate for therapeutic use, no